Business Description
JBM (Healthcare) Ltd
ISIN : KYG1090B1077
Share Class Description:
HKSE:02161: Ordinary SharesCompare
Compare
Traded in other countries / regions
02161.Hong Kong IPO Date
2021-02-05Description
JBM (Healthcare) Ltd markets and distributes healthcare products. The company's operating segment includes Branded medicines; Proprietary Chinese medicines and Health and wellness products. It generates maximum revenue from the Proprietary Chinese medicines segment. The Proprietary Chinese medicines segment develops, manufactures, and distributes registered Chinese medicines composed solely of any Chinese herbal medicines specified in the Chinese Medicine Ordinance, or any materials of herbal, animal, or mineral origin customarily or widely used by the Chinese. Geographically, it derives a majority of its revenue from Hong Kong.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.06 | |||||
| Equity-to-Asset | 0.7 | |||||
| Debt-to-Equity | 0.14 | |||||
| Debt-to-EBITDA | 0.64 | |||||
| Interest Coverage | 26.29 | |||||
| Piotroski F-Score | 8/9 | |||||
| Altman Z-Score | 3.84 | |||||
| Beneish M-Score | -2.84 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 14.6 | |||||
| 3-Year EBITDA Growth Rate | 19.8 | |||||
| 3-Year EPS without NRI Growth Rate | 72.2 | |||||
| 3-Year FCF Growth Rate | 67 | |||||
| 3-Year Book Growth Rate | 4.9 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 97.67 | |||||
| 9-Day RSI | 93.46 | |||||
| 14-Day RSI | 89.57 | |||||
| 6-1 Month Momentum % | 4.17 | |||||
| 12-1 Month Momentum % | -9.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 1.66 | |||||
| Quick Ratio | 1.25 | |||||
| Cash Ratio | 0.64 | |||||
| Days Inventory | 70.49 | |||||
| Days Sales Outstanding | 66.29 | |||||
| Days Payable | 27.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 4.69 | |||||
| Dividend Payout Ratio | 0.4 | |||||
| Forward Dividend Yield % | 6.89 | |||||
| 5-Year Yield-on-Cost % | 4.69 | |||||
| 3-Year Average Share Buyback Ratio | 2.4 | |||||
| Shareholder Yield % | 13.39 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 51.75 | |||||
| Operating Margin % | 26.62 | |||||
| Net Margin % | 22.74 | |||||
| FCF Margin % | 25.12 | |||||
| ROE % | 16.62 | |||||
| ROA % | 11.64 | |||||
| ROIC % | 14.06 | |||||
| ROC (Joel Greenblatt) % | 83.07 | |||||
| ROCE % | 17.55 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 8.72 | |||||
| PE Ratio without NRI | 8.99 | |||||
| Price-to-Owner-Earnings | 9.93 | |||||
| PEG Ratio | 0.82 | |||||
| PS Ratio | 2.05 | |||||
| PB Ratio | 1.45 | |||||
| Price-to-Tangible-Book | 10.63 | |||||
| Price-to-Free-Cash-Flow | 8.57 | |||||
| Price-to-Operating-Cash-Flow | 8.17 | |||||
| EV-to-EBIT | 6.99 | |||||
| EV-to-EBITDA | 6.99 | |||||
| EV-to-Revenue | 2.03 | |||||
| EV-to-FCF | 7.6 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.08 | |||||
| Price-to-Graham-Number | 2.36 | |||||
| Earnings Yield (Greenblatt) % | 14.31 | |||||
| FCF Yield % | 13.08 | |||||
| Forward Rate of Return (Yacktman) % | 15.91 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
JBM (Healthcare) Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 720.54 | ||
| EPS (TTM) (HK$) | 0.195 | ||
| Beta | 0.59 | ||
| Volatility % | 23.55 | ||
| 14-Day RSI | 89.57 | ||
| 14-Day ATR (HK$) | 0.088335 | ||
| 20-Day SMA (HK$) | 1.3525 | ||
| 12-1 Month Momentum % | -9.91 | ||
| 52-Week Range (HK$) | 0.86 - 1.88 | ||
| Shares Outstanding (Mil) | 814 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 8 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
JBM (Healthcare) Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
JBM (Healthcare) Ltd Stock Events
| Event | Date | Price(HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
JBM (Healthcare) Ltd Frequently Asked Questions
What is JBM (Healthcare) Ltd(HKSE:02161)'s stock price today?
The current price of HKSE:02161 is HK$1.70. The 52 week high of HKSE:02161 is HK$1.88 and 52 week low is HK$0.86.
When is next earnings date of JBM (Healthcare) Ltd(HKSE:02161)?
The next earnings date of JBM (Healthcare) Ltd(HKSE:02161) is .
Does JBM (Healthcare) Ltd(HKSE:02161) pay dividends? If so, how much?
The Dividend Yield %  of JBM (Healthcare) Ltd(HKSE:02161) is 4.69% (As of Today), Highest Dividend Payout Ratio of JBM (Healthcare) Ltd(HKSE:02161) was 0.42. The lowest was 0.09. And the median was 0.25. The  Forward Dividend Yield % of JBM (Healthcare) Ltd(HKSE:02161) is 6.89%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers